FDA Drug Approval Decisions Expected in August 2025
-
Clinician Roundtable: Experts Discuss Barriers in JIA Management and Measures to Improve OutcomesIn observance of Juvenile Arthritis Awareness Month, we conducted a roundtable discussion with experts in the field of pediatric rheumatology. -
Call for Clinicians to Speak Up for Gender-Affirming Health Care: Q&A With Dallas DucarThe Clinical Advisor spoke with NP Dallas Ducar about what clinicians can do amidst the current social and political landscape to adequately care for their transgender and gender-diverse patients. -
Is PCOS an Autoimmune Disease?This in-depth feature explores the shared pathogenetic mechanisms that link polycystic ovary syndrome and systemic autoimmune diseases. -
Navigating the Changing Landscape of LGBTQ+ Health Care: Q&A With Carlos Gutiérrez, EdD, MMS, PA-CThe Clinical Advisor spoke with Carlos Gutiérrez, EdD, MMS, PA-C, about the impact of Executive Orders on LGBTQ+ health care. -
ACR Releases Full 2024 Guideline for Managing Lupus NephritisThe full recommendations are a follow-up to the summary released during the ACR Convergence 2024 and is the first lupus nephritis guideline since 2012.
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
- Axial Spondyloarthritis
- Connective Tissue Disease
- Crystal Arthropathies
- Diseases of Bone and Cartilage
- General Medicine
- General Rheumatology
- Infection in Rheumatic Disease
- Musculoskeletal Pain
- Myositis
- Osteoarthritis
- Pediatric Rheumatology
- Practice Management
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Sjögren Syndrome
- Systemic Lupus Erythematosus
- Vasculitis
